| Bill S Noland Jr, CRNP | |
|
2609 Village Professional Dr, Suite 3, Opelika, AL 36801-4785 | |
| (334) 749-6523 | |
| (334) 742-0242 |
| Full Name | Bill S Noland Jr |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 17 Years |
| Location | 2609 Village Professional Dr, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215124557 | NPI | - | NPPES |
| 1215124557 | Other | AL | NPI |
| 122759 | Medicaid | AL | |
| 122762 | Medicaid | AL | |
| 1134289580 | Medicaid | AL | |
| 528701590 | Medicaid | AL | |
| 1215124557 | Other | NPI | |
| 122761 | Medicaid | AL | |
| 122756 | Medicaid | AL | |
| 122765 | Medicaid | AL | |
| CC1726 | Other | AL | RRMC |
| 122760 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WN0300X | Registered Nurse - Nephrology | 1-041332 (Alabama) | Secondary |
| 363L00000X | Nurse Practitioner | 2716 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hypertension And Nephrology | 3971529793 | 6 |
News Archive
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
Amyotrophic lateral sclerosis (ALS) is one of the most devastating adult-onset neurodegenerative diseases. Patients, including the late actor/playwright Sam Shepard, become progressively weaker and eventually paralyzed as their motor neurons degenerate and die.
A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.
More than a dozen states have passed legislation expanding the role of nurse practitioners (NPs) so they can help fill the shortage of primary care providers in the U.S. But a new study from Columbia University School of Nursing, published in the Journal of Professional Nursing, suggests that the organization and culture in health care settings often impedes the full utilization of NPs so that state laws expanding scope of practice may not be sufficient to relieve the nation's primary care crisis.
Does a specific memory exist for events involving humans, French researchers from the Vulnerability, Adaptation and Psychopathology Laboratory (CNRS/Universit' Paris VI) and Canadian researchers from Douglas Hospital, McGill University (Montreal) have identified the internal part of the prefrontal cortex as the key structure for the memory formation of social information.
› Verified 4 days ago
| Entity Name | Hypertension & Nephrology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134289580 PECOS PAC ID: 3971529793 Enrollment ID: O20051020001031 |
News Archive
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
Amyotrophic lateral sclerosis (ALS) is one of the most devastating adult-onset neurodegenerative diseases. Patients, including the late actor/playwright Sam Shepard, become progressively weaker and eventually paralyzed as their motor neurons degenerate and die.
A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.
More than a dozen states have passed legislation expanding the role of nurse practitioners (NPs) so they can help fill the shortage of primary care providers in the U.S. But a new study from Columbia University School of Nursing, published in the Journal of Professional Nursing, suggests that the organization and culture in health care settings often impedes the full utilization of NPs so that state laws expanding scope of practice may not be sufficient to relieve the nation's primary care crisis.
Does a specific memory exist for events involving humans, French researchers from the Vulnerability, Adaptation and Psychopathology Laboratory (CNRS/Universit' Paris VI) and Canadian researchers from Douglas Hospital, McGill University (Montreal) have identified the internal part of the prefrontal cortex as the key structure for the memory formation of social information.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bill S Noland Jr, CRNP 2609 Village Professional Dr, Suite 3, Opelika, AL 36801-4785 Ph: (334) 749-6523 | Bill S Noland Jr, CRNP 2609 Village Professional Dr, Suite 3, Opelika, AL 36801-4785 Ph: (334) 749-6523 |
News Archive
Genzyme, a Sanofi company, announced today top-line results from the TOWER (Teriflunomide Oral in people With relapsing remitting multiplE scleRosis) trial that assessed the efficacy and safety of once-daily, oral teriflunomide in patients with relapsing forms of multiple sclerosis.
Amyotrophic lateral sclerosis (ALS) is one of the most devastating adult-onset neurodegenerative diseases. Patients, including the late actor/playwright Sam Shepard, become progressively weaker and eventually paralyzed as their motor neurons degenerate and die.
A new drug that prompts cancer cells to self-destruct while sparing healthy cells is now entering phase I clinical trials in humans. The drug, called PAC-1, first showed promise in the treatment of pet dogs with spontaneously occurring cancers, and is still in clinical trials in dogs with osteosarcoma.
More than a dozen states have passed legislation expanding the role of nurse practitioners (NPs) so they can help fill the shortage of primary care providers in the U.S. But a new study from Columbia University School of Nursing, published in the Journal of Professional Nursing, suggests that the organization and culture in health care settings often impedes the full utilization of NPs so that state laws expanding scope of practice may not be sufficient to relieve the nation's primary care crisis.
Does a specific memory exist for events involving humans, French researchers from the Vulnerability, Adaptation and Psychopathology Laboratory (CNRS/Universit' Paris VI) and Canadian researchers from Douglas Hospital, McGill University (Montreal) have identified the internal part of the prefrontal cortex as the key structure for the memory formation of social information.
› Verified 4 days ago
Brian Clay Young, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 638 Lee Road 483, Opelika, AL 36804 Phone: 770-547-3632 | |
Mrs. Brandy D Mcculloch, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-1112 Fax: 334-528-1547 | |
Ms. Karen Ann Land, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2401 Village Professional Pkwy, Opelika, AL 36801 Phone: 334-749-8121 Fax: 334-749-6166 | |
Sandy Whitaker, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3320 Skyway Dr, Suite 801, Opelika, AL 36801 Phone: 334-821-0238 Fax: 334-821-6685 | |
Mrs. Nancy Mcdonald, CRNP, NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2000 Pepperell Pkwy, Opelika, AL 36801 Phone: 334-528-7200 Fax: 334-528-3470 | |
Mrs. Sylvia Anderson, N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 121 N 20th St, #6, Opelika, AL 36801 Phone: 334-749-3385 Fax: 334-745-7672 | |
Kristin Ann Mealer, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 300 Lee Road 29, Opelika, AL 36804 Phone: 334-733-0336 |